Concepedia

Intravenous arketamine for treatment-resistant depression: open-label pilot study

Gustavo C. Leal, Igor D. Bandeira, Fernanda S. Correia‐Melo, Manuela Telles, Rodrigo P. Mello, Flávia Vieira, Cassio Santos‐Lima, Ana Paula Jesus‐Nunes, Lívia N. F. Guerreiro‐Costa, Roberta Ferrari Marback,

European Archives of Psychiatry and Clinical Neuroscience · 2020 · 257 citations · 24 references

DOIFull text

Open access

Concepts

References

24

A New Depression Scale Designed to be Sensitive to Change

Stuart Montgomery, Marie Åsberg · The British Journal of Psychiatry · 1979 · 13.9K citations

, , +17

Antidepressant effects of ketamine in depressed patients

Robert Berman, Angela Cappiello, Amit Anand et al. · Biological Psychiatry · 2000 · 3.8K citations

, , +14

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson et al. · Archives of General Psychiatry · 2006 · 3.8K citations · Full text

, , +17

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

James W. Murrough, Dan V. Iosifescu, Lee C. Chang et al. · American Journal of Psychiatry · 2013 · 1.2K citations · Full text

, , +17

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

Vanina Popova, Ella Daly, Madhukar H. Trivedi et al. · American Journal of Psychiatry · 2019 · 872 citations · Full text

, , +17